Fol. Biol. 2011, 57, 173-181
https://doi.org/10.14712/fb2011057050173
Chromogranin A in Physiology and Oncology
References
1. , J. A., Gill, B. M., Takiyyuddin, M. A., O’Connor, D. T. (1991) Chromogranin A: posttranslational modifications in secretory granules. Endocrinology 128, 174-190.
<https://doi.org/10.1210/endo-128-1-174>
2. , E., Bidart, J. M., Bachelot, A., Ducreux, M., Elias, D., Ruffié, P., Schlumberger, M. (2001) Impact of chromogranin A measurement in the work-up of neuroendocrine tumours. Ann. Oncol. 12, 879-882.
<https://doi.org/10.1023/A:1012494309486>
3. , R., Šafařík, L., Ciprová, V., Vlček, P., Lisá L. (2008) Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma. Physiol. Res. 57 (Suppl. 1), 171-179.
<https://doi.org/10.33549/physiolres.931502>
4. , L. J. (1991) Chromogranin A – its role in endocrine function and as endocrine and neuroendocrine tumour marker. Endocr. Rev. 12, 181-187.
<https://doi.org/10.1210/edrv-12-2-181>
5. , F., Goumon, Y., Jacquemart, L., Vidaud, C., Bellanger, L., Pons-Anicet, D., Sequin, P., Metz-Boutigue, M. H., Aunis, D. (1999) A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245). Br. J. Cancer 79, 65-71.
<https://doi.org/10.1038/sj.bjc.6690013>
6. , M., Gouze, V., Huglo, D., Nocaudie, M., Pattou, F., Proye, C., Wemeau, J. L., Marchandise, X. (2001) Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J. Nucl. Med. 42, 993-997.
7. , B., Öberg, K., Stridsberg, M. (2000) Tumour markers in neuroendocrine tumours. Digestion 62 (Suppl.1), 33-38.
<https://doi.org/10.1159/000051853>
8. , S. A., Eiden, L. E. (2003) The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocr. Pathol. 14, 3-23.
<https://doi.org/10.1385/EP:14:1:3>
9. , L., Seregni, E., Bajetta, E., Martinetti, A., Bombardieri, E. (1999) The biological characteristic of chromogranin A and its role as a circulating marker in euroendocrine tumours. Anticancer Res. 19, 3415-3428.
10. , A., Sidoli, A., Sanchez, L. P., Longhi, R., Siccardi, A. G., Marchisio, P. C., Corti, A. (1997) Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. J. Biol. Chem. 272, 20835-20843.
<https://doi.org/10.1074/jbc.272.33.20835>
11. Giovanella, L. C. (2000) Chromogranin A, a circulating neuroendocrine marker. Biological background, analytical methods and clinical applications. Monograph, Schering p. 39.
12. , L., Squin, N., Ghelfo, A., Ceriani, L. (2006) Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan. Q. J. Nucl. Med. Mol. Imaging 50, 344-347.
13. , C., Santos-Alvarez, J., Sánchez-Marga. (2001) Pancreastatin, a chromogranin A-derived peptide, activates Gα(16) and phospholipase C-β(2) by interacting with specific receptors in rat heart membranes. Cell. Signal. 13, 43-49.
<https://doi.org/10.1016/S0898-6568(00)00127-3>
14. , G. N., Bevan, S., Mattei, M.-G., Mouland, A. J. (1995) Chromogranin A. Clin. Invest. Med. 18, 47-65.
15. , R. A., Mezger, M. S., O’Connor, D. T. (1990) Chromogranin A in uremia: Progressive retention of immunoreactive fragments. Kidney Int. 37, 955-964.
<https://doi.org/10.1038/ki.1990.71>
16. , E. T., Holmberg, L., Stridsberg, M. (1997) Carcinoid tumours: Analysis of prognostic factors and survival in 301 patients from a referral center. Ann. Oncol. 8, 685-690.
<https://doi.org/10.1023/A:1008215730767>
17. , Q., Taupenot, L., Mahata, S. K., Mahata, M., O ́Connor, D. T., Miles, L. A., Parmer, R. J. (2001) Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J. Biol. Chem. 276, 25022-25029.
<https://doi.org/10.1074/jbc.M101545200>
18. , J. H., Saunders, P. T., Wessels, J. A. (1999) The chromogranins and the counter-regulatory hormones: do they make homeostatic sense? J. Physiol. 517, 643-649.
<https://doi.org/10.1111/j.1469-7793.1999.0643s.x>
19. , F. R., Kwekkeboom, D. J., Bouillon, R., Lamberts, S. W. J. (1998) Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur. J. Clin. Invest. 28, 431-440.
<https://doi.org/10.1046/j.1365-2362.1998.00305.x>
20. , K., Tiensuu Janson, E. M., Eriksson, B. (1999) Tumour markers in neuroendocrine tumours. Ital. J. Gastroenterol. Hepatol. 31, (Suppl. 2), 160-162.
21. , P., Gerdes, H. H. (1994) The granin family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumours. J. Endocrinol. Invest. 17, 207-225.
<https://doi.org/10.1007/BF03347721>
22. , G., Betzler, M., Buhr, H. J. (1990) Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of gastro-entero-pancreatic system. Eur. J. Surg. Oncol. 16, 298-303.
23. , V., Massironi, S., Conte, D., Caprioli, F., Ferrero, S., Ciafardini, C., Peracchi, M., Bardella, M. T., Piodi, L. (2009) Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 867-871.
<https://doi.org/10.1002/ibd.20851>
24. , R. E., Memoli, V., Deftos, L. J. (1989) Hormone-negative, chromogranin A-positive endocrine tumours. N. Engl. J. Med. 320, 444-447.
<https://doi.org/10.1056/NEJM198902163200707>
25. , J. M., Goumon, Y., Lugardon, K., Capon, C., Lopez, M., Moniatte, M., Van Dorsselaer, A., Aunis, D., MetzBoutigue, M. H. (1996) Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J. Biol. Chem. 271, 28533-28540.
<https://doi.org/10.1074/jbc.271.45.28533>
26. , M. A., Cervenka, J. H., Hsiao, R. J., Barbosa, J. A., Parmer, R. J., O ́Connor, D. T. (1990) Chromogranin A. Storage and release in hypertension. Hypertension 15, 237-246.
<https://doi.org/10.1161/01.HYP.15.3.237>
27. , L., Harper, K., O’Connor, D. T. (2003) The chromogranin-secretogranin family. N. Engl. J. Med. 348, 1134-1149.
<https://doi.org/10.1056/NEJMra021405>
28. , M. C., Torta, M., Leon, A., Ambrosio, M. R., Gion, M., Tomassetti, P. (2007) Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. Endocr. Relat. Cancer, 14, 473-482.
<https://doi.org/10.1677/ERC-07-0001>
